Associations of the C-reactive protein-albumin-lymphocyte index with all-cause and cardiovascular mortality among individuals with cardiovascular disease: evidence from the NHANES 2001–2010
Authors:
Top Cited Papers
Open Access
- 3 March 2025
- journal article
- research article
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 25 (1) , 1-11
Abstract
Evidence regarding the C-reactive protein‒albumin‒lymphocyte (CALLY) index and mortality risk in individuals with cardiovascular disease (CVD) is scarce. This study investigated the relationships of the CALLY index with all-cause and cardiovascular mortality risk in CVD patients among American adults. This study enrolled 2183 CVD individuals from five NHANES cycles (2001–2010), and mortality outcomes were determined by linking the data to National Death Index (NDI) records up to December 31, 2019. Weighted multivariate Cox regression models and subgroup analyses were performed to assess the associations of the CALLY index with all-cause and cardiovascular mortality. A restricted cubic spline (RCS) was used to visualize the association of the CALLY index with mortality risk. During a median follow-up of 122 months (interquartile range, 71–157 months), 1208 (weighted percentage, 49.62%) of the 2183 CVD individuals died, including 398 (weighted percentage, 24.85%) with cardiovascular deaths and 810 (weighted percentage, 75.15%) with noncardiovascular deaths. Cox regression revealed an inverse correlation between the CALLY index and the risk of all-cause and cardiovascular mortality after adjusting for covariates. Compared with individuals with a lower CALLY index, those with a higher CALLY index had a significantly lower risk of both all-cause (HR 0.58, 95% CI: 0.48, 0.71, p < 0.001) and cardiovascular mortality (HR 0.54, 95% CI: 0.38, 0.76, p < 0.001). The RCS regression analysis revealed a nonlinear association between the CALLY index and all-cause and cardiovascular mortality (p < 0.05 for nonlinearity) in CVD patients. The associations were consistent in the subgroup analyses regardless of age, sex, income, education level, race, smoking status, diabetes, and hypertension (all p values for interactions > 0.05). An increased CALLY index is independently associated with decreased all-cause and cardiovascular mortality in CVD patients.Keywords
Funding Information
- Youth Science Fund Project (82100263)
This publication has 47 references indexed in Scilit:
- Preoperative albumin to globulin ratio predicts survival in clear cell renal cell carcinoma patientsOncotarget, 2017
- Chronic Heart Failure and InflammationCirculation Research, 2016
- CRIBADO NUTRICIONAL; CONTROL DE LA DESNUTRICIÓN CLÍNICA CON2014
- Human serum albumin: From bench to bedsideMolecular Aspects of Medicine, 2012
- Usefulness of Total Lymphocyte Count as Predictor of Outcome in Patients With Chronic Heart FailureThe American Journal of Cardiology, 2011
- Sex differences in the association between albumin and all‐cause and vascular mortalityEuropean Journal of Clinical Investigation, 2009
- Inflammation and Cardiovascular DiseaseCirculation, 2008
- Use of BNP and CRP as Biomarkers in Assessing Cardiovascular Disease:Diagnosis Versus RiskCurrent Vascular Pharmacology, 2007
- Serum albumin and risk of stroke, coronary heart disease, and mortality: the role of cigarette smokingJournal of Clinical Epidemiology, 2004
- Serum Albumin Level as a Predictor of Incident Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) StudyAmerican Journal of Epidemiology, 2000